Valuation: Guerbet

Market Cap 94.87M 108M 88.55M 81.27M 152M 10.34B 156M 1.05B 411M 5.12B 405M 397M 17.69B P/E 2026 *
-4.22x
P/E 2027 * 8.18x
Enterprise Value 470M 535M 439M 403M 754M 51.28B 773M 5.21B 2.04B 25.38B 2.01B 1.97B 87.73B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.58x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.1%
1 day+1.46%
1 week-14.17%
Current month-15.69%
1 month-17.07%
3 months-34.22%
6 months-44.14%
Current year-46.64%
1 week 7.43
Extreme 7.43
8.94
1 month 7.43
Extreme 7.43
9.29
Current year 7.43
Extreme 7.43
15.12
1 year 7.43
Extreme 7.43
23.1
3 years 7.43
Extreme 7.43
40.25
5 years 7.43
Extreme 7.43
45.65
10 years 7.43
Extreme 7.43
90.64
Manager TitleAgeSince
Chief Executive Officer - 02/02/2026
Chief Executive Officer - 22/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 29/05/2015
Director/Board Member 49 19/05/2017
Director/Board Member 51 22/11/2023
Date Insider Type Main position Quantity % Market Cap.
13/11/25 Buy

Director

90 0.0007%
13/11/25 Buy

Director

1,100 0.0087%
10/10/25 Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%-14.17%-65.86%-64.26% 108M
+2.70%-0.47%-17.23%-21.68% 13.44B
+0.07%-8.14%+39.48%-12.31% 3.99B
-0.42%+1.35%+64.97%+117.05% 1.21B
+1.46%+2.25%-39.18%-59.33% 1.21B
+2.46%+3.43%-38.94%-47.00% 1.1B
+2.86%-2.96%-45.13% - 907M
-0.61%-1.93%+25.62%+80.83% 468M
+0.98%-2.89%+47.80% - 331M
-2.71%-10.44%-62.26%+196.20% 250M
Average +0.88%-2.83%-9.07%+23.69% 2.3B
Weighted average by Cap. +1.87%-0.71%-5.27%-11.12%

Financials

2026 *2027 *
Net sales 764M 869M 713M 654M 1.22B 83.26B 1.26B 8.45B 3.31B 41.2B 3.26B 3.19B 142B 798M 908M 745M 684M 1.28B 87.01B 1.31B 8.84B 3.46B 43.06B 3.41B 3.34B 149B
Net income -35.8M -40.74M -33.42M -30.67M -57.41M -3.9B -58.82M -396M -155M -1.93B -153M -150M -6.68B 8.3M 9.45M 7.75M 7.11M 13.31M 905M 13.64M 91.87M 35.93M 448M 35.46M 34.69M 1.55B
Net Debt 376M 427M 351M 322M 602M 40.94B 617M 4.16B 1.63B 20.26B 1.6B 1.57B 70.04B 370M 421M 346M 317M 594M 40.37B 608M 4.1B 1.6B 19.98B 1.58B 1.55B 69.05B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
30/07/26 EUR 7.630 +1.46% 11,979
28/07/26 EUR 7.520 -2.84% 17,949
27/07/26 EUR 7.740 -6.07% 51,382
24/07/26 EUR 8.240 -6.68% 57,840
23/07/26 EUR 8.830 -0.67% 5,451
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
7.520EUR
Average target price
8.433EUR
Spread / Average Target
+12.15%

Quarterly revenue - Rate of surprise